RenaissanceRe's ILS Platform Supports Fee-Based Earnings Growth

RenaissanceRe Holdings Ltd. RNR is benefiting from the growing use of insurance-linked securities (ILS), which is creating opportunities to expand its fee-based income. This could help offset some pressure from moderating reinsurance pricing.

ILS allows investors to provide capital for insurance risks, particularly catastrophe risks. As more alternative capital enters the market, insurers have greater access to reinsurance capacity. AM Best reported that 144A property-catastrophe bond issuance reached a record $17.3 billion in the first half of 2026. At mid-year renewals, reinsurance supply exceeded demand by more than 25%, contributing to a further decline in reinsurance pricing.

While softer pricing can pressure reinsurance premium growth and margins, RNR can benefit from the same trend through its Capital Partners business. This enables the company to participate in the growing ILS market while generating management and performance fees from third-party capital.

RNR's fee income increased to $177.2 million in the first half of 2026 from $125.4 million a year earlier, supported by higher performance fees. This growing fee-based income provides an additional earnings stream beyond traditional underwriting.

The Capital Partners platform, therefore, provides earnings diversification as alternative capital expands. While rising ILS capacity can pressure traditional reinsurance pricing, RNR's ability to manage that capital and generate fee income from it provides an important offset.

Overall, RNR's ability to manage third-party capital allows it to benefit from ILS growth, supporting fee-based income and earnings diversification.

How Are Competitors Faring?

Everest Group Ltd. EG is expanding its third-party capital platform through Mt. Logan Capital Management. Its third-party capital reached approximately $3.4 billion as of July 1, 2026, up 89% from the beginning of 2025, helped by the launch of its $600 million Annapurna Re casualty sidecar. Everest expects the platform to provide additional capital flexibility, support growth and generate fee income.

Arch Capital Group Ltd. ACGL has also been expanding its third-party capital business, which it has operated since 2006. Its ILS platform mainly invests in property-catastrophe reinsurance risks. This allows Arch to use outside investor capital to expand its reinsurance capacity without relying entirely on its own capital.

RNR’s Price Performance

Shares of RNR have gained 36.1% in the past year compared with the industry’s growth of 1.6%.

Image Source: Zacks Investment Research

Attractive Valuation of RNR

RNR’s shares are trading at a discount compared with the industry. Its trailing 12-month price-to-book value of 1.24X is lower than the industry average of 1.43X

Image Source: Zacks Investment Research

RNR’s Growth Projection

The Zacks Consensus Estimate for RNR’s 2026 earnings per share (EPS) is pinned at $42.40, indicating a year-over-year decrease of 8.4%. The consensus estimate for revenues is pegged at $10.35 billion, implying a year-over-year decrease of 10.8%.

The consensus estimate for 2027 EPS and revenues indicates a decrease of 4% and 1.4%, respectively, from the corresponding 2026 estimates.

The Zacks Consensus Estimate for 2026 earnings has moved north 1.1%, while the metric for 2027 has moved south 0.2%, in the past 30 days.

Image Source: Zacks Investment Research

RNR stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research